Clinical trialNCT03764735CompletedPhase 3Interventional

Study of SkQ1 as Treatment for Dry-eye Syndrome

SponsorMitotech, SAEnrollment452Dry Eye Syndrome

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to evaluate whether SkQ1 ophthalmic solutions are safe and effective compared to placebo for the treatment of the signs and symptoms of dry eye syndrome.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

Lawrence T Friedhoff, MD, PhD
Mitotech, SA
Study Chair
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Cornea & Cataract Consultants of Arizona
Phoenix, Arizona, United States
Eye Research Foundation
Newport Beach, California, United States
Eye Care Insititute
Louisville, Kentucky, United States
Central Maine Eye Care
Lewiston, Maine, United States
Andover Eye Associates
Andover, Massachusetts, United States
Vita Eye Clinic
Shelby, North Carolina, United States
Total Eye Care, Pa
Memphis, Tennessee, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

High dose - SkQ1Low Dose - SkQ1SkQ1

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 6 Dec 2018
Primary completion: 9 Feb 2019
Completion: 9 Feb 2019
Last update posted: 19 Jan 2022
Registered enrollment: 452
Registry id: NCT03764735

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.